Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Markets

Anheuser-Busch InBev SA/NV (NYSE:BUD): A Fundamentally Weighted Stock for Long-Term Investors

December 30, 2022
in Markets

The stock of Anheuser-Busch InBev SA/NV (NYSE:BUD) last traded at $60.38, up 0.70% from the previous session.

Data from the available sources indicates that Anheuser-Busch InBev SA/NV (NYSE:BUD) is covered by 30 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $70.00 and a low of $53.50, we find $60.00. Given the previous closing price of $59.96, this indicates a potential upside of 0.07 percent. BUD stock price is now 9.50% away from the 50-day moving average and 11.43% away from the 200-day moving average. The market capitalization of the company currently stands at $104.75B.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

In total, 8 analysts have assigned it a hold rating, and 18 have given it a buy rating. Brokers who have rated the stock have averaged $61.36 as their price target over the next twelve months.

On November 28, 2022, JP Morgan Upgraded its previous ‘Underweight’ rating to ‘Overweight’ on the stock increasing its target price from $45 to quote $70, while ‘Jefferies’ rates the stock as ‘Hold’.

A total of 53.90% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in BUD stock. A new stake in Anheuser-Busch InBev SA/NV shares was purchased by OLD MISSION CAPITAL, LLC during the first quarter worth $13,571,000. ALERUS FINANCIAL NA invested $11,641,000 in shares of BUD during the first quarter. In the first quarter, CAUSEWAY CAPITAL MANAGEMENT LLC acquired a new stake in Anheuser-Busch InBev SA/NV valued at approximately $7,916,000. TREXQUANT INVESTMENT LP acquired a new stake in BUD for approximately $4,555,000. CAPRICORN FUND MANAGERS LTD purchased a new stake in BUD valued at around $4,085,000 in the second quarter. In total, there are 549 active investors with 6.80% ownership of the company’s stock.

With an opening price of $60.50 on Thursday morning, Anheuser-Busch InBev SA/NV (NYSE: BUD) set off the trading day. During the past 12 months, Anheuser-Busch InBev SA/NV has had a low of $44.51 and a high of $67.91. As of last week, the company has a debt-to-equity ratio of 1.17, a current ratio of 0.70, and a quick ratio of 0.50. The fifty day moving average price for BUD is $55.14 and a two-hundred day moving average price translates $54.19 for the stock.

The latest earnings results from Anheuser-Busch InBev SA/NV (NYSE: BUD) was released for Jun, 2022. According to the Beverages – Brewers Company, earnings per share came in at $0.84, beating analysts’ expectations of $0.77 by 0.07. This compares to $0.33 EPS in the same period last year. The net profit margin was 8.90% and return on equity was 7.30% for BUD. The company reported revenue of $15.09 billion for the quarter, compared to $14.27 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.72 percent. For the current quarter, analysts expect BUD to generate $15.15B in revenue.

Moreover, the firm recently paid out its quarterly dividend on 06/02/2022. Investors who held shares on 05/04/2022 were paid a $0.527563 dividend. On an annualized basis, this represents a $1.13 dividend and a 1.87% percent yield. There was an ex-dividend date of 05/03/2022 for this dividend.

Anheuser-Busch InBev SA/NV(BUD) Company Profile

Anheuser-Busch InBev SA/NV engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck’s, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium.

Tags: Anheuser-Busch InBev SA/NVBUDBUD stockNYSE:BUD

Related Posts

Albany International Corp. (AIN) – it’s time to buy. Check out key Indicators

January 27, 2023

TrustCo Bank Corp NY (TRST) Price Aside, TRST Fundamentals Booming Beyond Compare

January 27, 2023

Do futuristic bulls still own PCB Bancorp [PCB] stock?

January 27, 2023

Stocks like ReWalk Robotics Ltd. [RWLK] still have plenty of sunny days ahead

January 27, 2023

RxSight Inc. (NASDAQ:RXST) Risks You Should Know Before Investing

January 27, 2023

Does Iveda Solutions Inc. (NASDAQ:IVDA) have deteriorating prospects?

January 27, 2023
Next Post

Before You Invest In Nerdy Inc. (NYSE:NRDY), Consider This Metric

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Do investors have a safe investment in HOOKIPA Pharma Inc. (NASDAQ:HOOK)?

4 days ago

There has been a significant shift in the fundamentals for Cellebrite DI Ltd. (NASDAQ:CLBT)

3 months ago

When is the right time to cash out of Texas Instruments Incorporated [TXN] stock?

2 months ago

Before Investing In Avis Budget Group Inc. (NASDAQ:CAR), Here Are Some Things To Consider

1 week ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch